跳至主要内容
临床试验/NCT00814528
NCT00814528撤回不适用

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

University of Chicago1 个研究点 分布在 1 个国家开始时间: 2007年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Actinic keratosis /incomplete therapy and reoccurence

研究概览

简要总结

The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil (5-FU).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-95 years old
  • Diagnosied with actinic keratoses.

排除标准

  • Patients who have had Isotretinoin therapy less that 1 year prior to screening.
  • Patients who have an adverse reaction to light exposure (for example photo- exacerbated seizures).
  • History of porphyria

研究组 & 干预措施

1

Experimental

Application of 5-ALA PDT to some lesions on skin with "Blue U" light source (417 nm).

干预措施: 5-ALA plus Blu-Light (Drug)

2

Experimental

5-FU, Imiquimod or treatment with cryotherapy to lesions on the skin.

干预措施: 5-FU, Imiquimod or treatment with cryotherapy (Drug)

结局指标

主要结局

Actinic keratosis /incomplete therapy and reoccurence

时间窗: 18 months

次要结局

  • Erythema(2 weeks post therapy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验